…
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs, lift chairs, and accessories and tables for armchairs; incontinence products, including sample wait, slip absorbent, adult complete change, incontinence diapers, and onesies, anatomical, male urinary, and right-hand protections, incontinence panties and swimsuits, disposable bed pads, support briefs, slips filets, feminine hygiene products, hygiene incontinence, and washable and reusable briefs and panties for urinary incontinence; and mobility products, such as walkers and rollators, walking sticks, electric scooters, and manual and electric wheelchairs. It also provides medical equipment comprising heating products, bathroom medical equipment, medical measuring device, medical pillow and cushion, technical support, electrostimulation and circulatory stimulators, pressotherapy device, pedal exerciser for seniors, seniors' telephone, bedside tables, medicalized room, sleep apnea device, natural food supplement, thermal compresses, pedicure and foot care, comfort shoes, first aid products, and wellness and health. In addition, the company offers professional equipment, which includes consumable for healthcare professionals, hygiene and disinfection, care and dressings, diagnosis and self-checking, and other medical equipment; and rental and services for medical bed, wheelchair, air mattress, patient lift, and verticalizer. It exports its products. The company was incorporated in 1976 and is headquartered in Caissargues, France. Bastide Le Confort Médical SA operates as a subsidiary of Societe d'Investissement Bastide SAS.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | 10.54M | 16.50M | 22.77M | 21.02M | 20.17M |
| Net income | 0.53M | -0.90M | 16.07M | 14.44M | 13.45M |
| Selling general administrative | - | - | - | - | 122.87M |
| Gross profit | 333.00M | 354.44M | 333.73M | 306.80M | 280.26M |
| Ebit | 41.38M | 43.87M | 42.82M | 38.93M | 37.50M |
| Ebitda | 102.03M | 107.20M | 82.36M | 79.51M | 72.77M |
| Depreciation and amortization | 60.64M | 63.33M | 39.54M | 40.58M | 35.27M |
| Operating income | 39.17M | 38.92M | 42.82M | 38.93M | 37.50M |
| Other operating expenses | 452.01M | 490.83M | 468.67M | 437.08M | 415.00M |
| Interest expense | 30.84M | 27.37M | - | - | 0.00M |
| Tax provision | - | - | - | - | 5.82M |
| Interest income | - | - | - | - | 8.13M |
| Income tax expense | 6.49M | 7.01M | 5.96M | 5.93M | 5.82M |
| Total revenue | 491.18M | 529.75M | 508.03M | 468.30M | 444.07M |
| Total operating expenses | 293.83M | 315.52M | 294.37M | 275.58M | 251.19M |
| Cost of revenue | 158.18M | 175.32M | 174.30M | 161.50M | 163.81M |
| Total other income expense net | -28.63M | -22.42M | -20.06M | -17.92M | -17.33M |
| Discontinued operations | - | - | - | -0.76M | -0.76M |
| Net income applicable to common shares | - | - | - | 13.68M | 13.45M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 661.03M | 647.07M | 657.08M | 632.55M | 569.11M |
| Intangible assets | 9.93M | 8.84M | 8.21M | 8.47M | 7.15M |
| Other current assets | 112.22M | 19.00M | 29.85M | 35.18M | 19.02M |
| Total liab | 589.73M | 566.34M | 568.99M | 545.89M | 484.05M |
| Total stockholder equity | 72.13M | 79.77M | 87.65M | 84.56M | 81.31M |
| Other current liab | 96.30M | 73.26M | 151.93M | 111.21M | 82.95M |
| Common stock | 3.36M | 3.36M | 3.36M | 3.31M | 3.31M |
| Retained earnings | 59.31M | 68.50M | 74.83M | 71.79M | 68.54M |
| Other liab | - | - | - | 7.60M | 10.80M |
| Good will | 182.03M | 208.63M | 225.66M | 217.61M | 184.13M |
| Other assets | 0.00M | - | 15.57M | 11.86M | 9.07M |
| Cash | 25.49M | 23.62M | 36.71M | 22.13M | 33.74M |
| Total current liabilities | 200.19M | 216.21M | 224.99M | 175.00M | 147.94M |
| Net debt | 385.67M | 385.03M | -36.71M | -22.13M | -33.74M |
| Short term debt | 29.63M | 65.92M | - | - | 0.45M |
| Short long term debt total | 411.16M | 408.65M | - | - | 325.31M |
| Other stockholder equity | 9.46M | 7.91M | 9.46M | 9.47M | 9.46M |
| Property plant equipment | - | - | - | 207.70M | 204.05M |
| Total current assets | 276.59M | 208.92M | 196.41M | 186.64M | 164.13M |
| Net tangible assets | - | - | - | -141.52M | -109.97M |
| Short term investments | - | 3.92M | - | - | - |
| Net receivables | 98.92M | 107.23M | 81.35M | 80.86M | 68.48M |
| Long term debt | - | - | - | - | 253.62M |
| Inventory | 39.96M | 59.07M | 48.50M | 48.47M | 42.89M |
| Accounts payable | 74.26M | 77.02M | 73.06M | 63.79M | 64.99M |
| Treasury stock | - | - | - | - | -1.31M |
| Non currrent assets other | 3.07M | 3.91M | -445.10M | -434.05M | -395.91M |
| Non current assets total | 384.44M | 438.14M | 445.10M | 434.05M | 395.91M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Investments | - | - | - | 0.52M | -0.41M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | -56.44M | -43.65M | - | -104.45M | -73.38M |
| Net borrowings | - | - | - | 42.44M | 12.54M |
| Total cash from financing activities | -4.33M | -35.55M | -7.89M | 29.43M | 1.34M |
| Change to operating activities | - | - | - | -28.86M | -1.23M |
| Net income | 1.56M | 7.38M | 12.05M | 13.68M | 13.45M |
| Change in cash | 1.08M | -13.09M | 21.51M | -18.08M | 2.83M |
| Begin period cash flow | 23.61M | 36.71M | 15.20M | 33.28M | 30.44M |
| End period cash flow | 24.69M | 23.62M | 36.71M | 15.20M | 33.28M |
| Total cash from operating activities | 71.87M | 66.04M | 105.68M | 56.86M | 74.36M |
| Depreciation | 60.64M | 63.33M | 58.19M | 59.42M | 50.80M |
| Other cashflows from investing activities | 1.43M | -0.54M | - | 0.28M | 0.07M |
| Dividends paid | 0.57M | 1.63M | - | 2.24M | 2.03M |
| Sale purchase of stock | -0.00M | - | - | -0.24M | -0.75M |
| Other cashflows from financing activities | -19.98M | -20.71M | 21.52M | 245.74M | 34.61M |
| Change to netincome | - | - | - | 14.81M | 11.35M |
| Capital expenditures | 60.08M | 55.40M | 53.63M | 53.27M | 46.51M |
| Change in working capital | 5.16M | -3.77M | - | - | 4.97M |
| Stock based compensation | - | - | 0.85M | 0.34M | 0.38M |
| Other non cash items | 4.51M | -0.90M | 34.60M | -16.58M | 9.73M |
| Free cash flow | 41.74M | 10.64M | 52.05M | 3.59M | 27.85M |
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| 0IP1 Bastide le Confort Medical S.A. |
0.04 0.22% |
17.84 | 0.14 | - | 0.36 | - |
| 0R15 SoftBank Group Corp. |
248.00 5.84% |
4494.00 | - | - | - | - |
| 0R1E Nintendo Co. Ltd. |
-115.00 1.34% |
8476.00 | - | - | - | - |
| 0LC3 Synchrony Financial |
2.34 3.20% |
75.60 | 0.09 | - | 4.97 | - |
| 0HQP CBRE Group Inc. Cl A |
0.15 0.12% |
122.47 | 0.25 | - | 1.18 | - |
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs, lift chairs, and accessories and tables for armchairs; incontinence products, including sample wait, slip absorbent, adult complete change, incontinence diapers, and onesies, anatomical, male urinary, and right-hand protections, incontinence panties and swimsuits, disposable bed pads, support briefs, slips filets, feminine hygiene products, hygiene incontinence, and washable and reusable briefs and panties for urinary incontinence; and mobility products, such as walkers and rollators, walking sticks, electric scooters, and manual and electric wheelchairs. It also provides medical equipment comprising heating products, bathroom medical equipment, medical measuring device, medical pillow and cushion, technical support, electrostimulation and circulatory stimulators, pressotherapy device, pedal exerciser for seniors, seniors' telephone, bedside tables, medicalized room, sleep apnea device, natural food supplement, thermal compresses, pedicure and foot care, comfort shoes, first aid products, and wellness and health. In addition, the company offers professional equipment, which includes consumable for healthcare professionals, hygiene and disinfection, care and dressings, diagnosis and self-checking, and other medical equipment; and rental and services for medical bed, wheelchair, air mattress, patient lift, and verticalizer. It exports its products. The company was incorporated in 1976 and is headquartered in Caissargues, France. Bastide Le Confort Médical SA operates as a subsidiary of Societe d'Investissement Bastide SAS.
Euro 2000 Centre, Caissargues, France, 30132
33 4 66 38 68 08
3641
| Name | Title | Year Born |
|---|---|---|
| Mr. Vincent Bastide | Chairman & CEO | NA |
| Ms. Dorothee Barvard | Head of Nutrition & Perfusion Division and Director | 1977 |
| Mr. Jean-Claude Brdenk | Deputy Chief Exec. Officer in Charge of Operations & Devel. | 1967 |
| Mr. Olivier Jourdanney | Deputy Chief Exec. Officer | NA |
| Mr. Benoit Quencez | Deputy Chief Exec. Officer | NA |
| Mr. Arnaud Fayolle | Deputy Chief Exec. Officer | NA |
| Pierre-Marie Varachaud | Deputy Chief Exec. Officer | NA |
| Mr. Arnaud Fayolle | Deputy Chief Executive Officer | NA |
| Pierre-Marie Varachaud | Deputy Chief Executive Officer | NA |
| Mr. Jeremy Lugagne | Deputy Chief Executive Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.